Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial

Adam Sacarny; Andrew R Olenski; Michael L Barnett

doi:10.1001/jamapsychiatry.2019.1418

Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial

JAMA Psychiatry. 2019 Oct 1;76(10):1094-1095. doi: 10.1001/jamapsychiatry.2019.1418.

Authors

Adam Sacarny^{1

2}, Andrew R Olenski³, Michael L Barnett⁴

Affiliations

¹ Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York.
² National Bureau of Economic Research, Cambridge, Massachusetts.
³ Department of Economics, Columbia University, New York, New York.
⁴ Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Abstract

This secondary analysis of a randomized clinical trial examines the association of antipsychotic overuse letters with changes in the prescription of quetiapine by physician peers.

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antipsychotic Agents / therapeutic use*
Drug Prescriptions* / standards
Drug Prescriptions* / statistics & numerical data
Humans
Interprofessional Relations*
Practice Patterns, Physicians'* / standards
Practice Patterns, Physicians'* / statistics & numerical data
Prescription Drug Overuse* / prevention & control
Prescription Drug Overuse* / statistics & numerical data
Quetiapine Fumarate / therapeutic use*

Substances

Antipsychotic Agents
Quetiapine Fumarate